This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Acologix, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovator Behind Phosphatonin: A Spotlight on Peter Rowe
Introduction
Peter Rowe is a prolific inventor based in Finchley, GB, known for his significant contributions to the field of biotechnology. With one patent to his name, he is recognized for his work on a novel human protein called phosphatonin, which has promising applications in diagnostic and therapeutic methods.
Latest Patents
Rowe's patent revolves around the invention of the polypeptide hormone phosphatonin. This innovation includes isolated polynucleotides that encode the phosphatonin protein. The patent also encompasses vectors, host cells, antibodies, and recombinant methods for producing this essential human protein. His work lays the groundwork for further exploration into disorders linked to phosphatonin, offering new diagnostic and treatment avenues.
Career Highlights
Peter Rowe is currently associated with Acologix, Inc., a company dedicated to advancing biotechnology. His innovative approach and focus on human proteins showcase his commitment to enhancing medical science and improving patient outcomes through groundbreaking research.
Collaborations
While specific collaborations have not been detailed, Rowe's position at Acologix, Inc. likely allows him to engage in partnerships with various research institutions and universities. Such collaborations could play a crucial role in the ongoing development and application of his patented technology.
Conclusion
Peter Rowe exemplifies the spirit of innovation within the biotechnology industry. His work on the phosphatonin hormone underscores the vital connection between scientific research and real-world medical applications. As he continues to advance his research through Acologix, Inc., Rowe's contributions hold the potential to shape the future of diagnostic and therapeutic health solutions.